• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Roche Holding AG ADR

Roche Holding AG ADR

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Roche Holding AG ADR RHHBY Q3 2012 Earnings Call Transcript

    Ladies and gentlemen, good morning or good afternoon, and welcome to the Roche Third Quarter 2012 Conference Call. I'm Zoya, the conference call operator. I would like to remind you that all participants will be in listen-only mode and the conference is being recorded. After the presentation there ...

  2. Roche Holding AG ADR RHHBY Q1 2012 Earnings Call Transcript

    Ladies and gentlemen, good morning or good afternoon. Welcome to the Roche's Fourth Quarter 2012 Conference Call. I'm Myra, the Chorus Call Operator. I would like to remind that all participants will be in listen-only mode and the conference is being recorded. After the presentation there will be a ...

  3. Roche Holding AG ADR RHHBY Q3 2011 Earnings Call Transcript

    Good morning or good afternoon, depending where we are attending from. I am Myra, the Chorus Call operator for this conference. Welcome to the Roche's Third Quarter 2011 Conference Call. Please note that for the duration of the presentation all participants would be in listen-only mode. The ...

  4. Roche Holding AG ADR RHHBY Q2 2011 Earnings Call Transcript

    Roche Holding AG Q2 2011 Earnings Conference Call.

  5. Roche Holding AG ADR RHHBY Q4 2011 Earnings Call Transcript

    Good afternoon, ladies and gentlemen, 2011 has been a good year for Roche. We achieved all our financial goals and very importantly we made significant progress in our late-stage pipeline.

  6. Roche Holding AG ADR RHHBY Q1 2011 Earnings Call Transcript

    Good morning or good afternoon, depending where you are attending from. I am Goran, the Chorus Call operator for this conference. Welcome to the Roche First Quarter 2011 Conference Call and Live Webcast. Please note that for the duration of the presentation all participants will be in listen-only ...

  7. Genentech’s Obinutuzumab (GA101) Significantly Reduced the Risk of Disease Progression or Death in People with One of the Most Common Forms of Blood Cancer

    Genentech’s Obinutuzumab (GA101) Significantly Reduced the Risk of Disease Progression or Death in People with One of the Most Common Forms of Blood Cancer

  8. Roche Considers Sale of Blood Glucose Meter Unit -Reuters

    Roche Considers Sale of Blood Glucose Meter Unit -Reuters

  9. Genentech to Present Important New Data Reflecting Broad Cancer Pipeline at ASCO

    Genentech to Present Important New Data Reflecting Broad Cancer Pipeline at ASCO

  10. FDA Approves Tarceva (Erlotinib) Tablets and Cobas EGFR Mutation Test for Specific Type of Lung Cancer

    FDA Approves Tarceva (Erlotinib) Tablets and Cobas EGFR Mutation Test for Specific Type of Lung Cancer

123
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.